CVE-2026-68067: Mira Hormone Monitor, Mira Android App Weak Authentication

Severity: critical (CVSS 9.8 v3.1)
Exploited in the wild: not listed in CISA KEV
EPSS: 0.5% probability of exploitation in the next 30 days
Public exploit or detection template: none known
Published: 2026-08-11 · updated 2026-09-01
Weakness: CWE-1390

Description

The login endpoint on the Mira cloud API accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker could use an email address to control cloud accounts and access hormone record information and account settings.

Affected products

Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Android App: 4.5.15.4
Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Firmware: 1.7.1.47

References

https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-223-01.json
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-223-01

Get alerted when CVE-2026-68067 or the next vulnerability affects your stack